"There is currently no evidence that additional treatment is needed with Paxlovid or other anti-SARS-CoV-2 therapies in cases where COVID-19 rebound is suspected," the CDC stated. Additionally, the CDC stressed that Paxlovid’s five-day regimen of pills is still recommended for early-sta...
What to know about Pfizer's COVID-19 vaccine for kids 5 to 11 Kids between the ages of 5 and 11 are now eligible to get the Pfizer-BioNTech COVID-19 vaccine. WASHINGTON (AP) - Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage ...